Pereira, Dhelio Batista https://orcid.org/0000-0002-7761-5498
Lacerda, Marcus Vinícius Guimarães https://orcid.org/0000-0003-3374-9985
Bilkhu, Pavandeep https://orcid.org/0009-0000-6452-7977
Duarte, Carolina https://orcid.org/0009-0003-1977-8410
Fiţa, Ioana-Gabriela https://orcid.org/0009-0000-1872-5278
Jackson, Felix https://orcid.org/0009-0001-3066-2406
Jones, Siôn https://orcid.org/0000-0003-1649-8133
Martin, Ana https://orcid.org/0000-0003-2050-898X
Rangel, Marcia https://orcid.org/0009-0004-3789-7920
Rolfe, Katie https://orcid.org/0000-0002-8635-4891
Teckkam, Alex https://orcid.org/0009-0007-7450-7719
Zajdenverg, Roberto https://orcid.org/0009-0000-8117-9185
Pingle, Anup https://orcid.org/0000-0002-9844-7323
Article History
Received: 10 July 2024
Accepted: 12 February 2025
First Online: 3 March 2025
Declarations
:
: Participant consent was obtained at the clinics through the PVCs or the study website. All information for participants was available in English and Brazilian Portuguese on the Seta study website. The study was approved by the Brazilian Research Ethics Committee (CONEP), reference number CAAE—35245220.8.0000.0005.
: Not applicable.
: Dhelio Batista Pereira and Marcus Vinícius Guimarães Lacerda received support from GSK for the conduct of the Seta study. Felix Jackson and Pavandeep Bilkhu are agency workers from medDigital Ltd contracted and paid by GSK to support the setup of the study, develop the Seta application, and write and review the study report. Carolina Duarte and Alex Teckkam were agency workers from medDigital Ltd during the time of the study. Felix Jackson also discloses being a major shareholder in medDigital Ltd. Marcia Rangel, Katie Rolfe, Siôn Jones, Ana Martin, Ioana-Gabriela Fiţa, Anup Pingle, and Roberto Zajdenverg are employed by and hold financial equities in GSK. Roberto Zajdenverg also received support from GSK to participate in medical conferences as a GSK employee. The authors declare no other financial or non-financial relationships and activities.